We characterized pharmacologically the slow conduction zone of verapamil-sensitive idiopathic left ventricular tachycardia (ILVT) with regard to the late diastolic potential (LDP). BACKGROUND We showed that the slow conduction zone of ILVT could be divided into two components by LDP; that is, the distal component with a tachycardia-dependent conduction delay property and the proximal one without it.
Verapamil-sensitive idiopathic left ventricular tachycardia (ILVT) constitutes a relatively small but distinct entity occurring in relatively young patients (1) (2) (3) (4) (5) (6) (7) (8) (9) . It has been shown in most patients that the underlying mechanism of ILVT is re-entry with an excitable gap (3) (4) (5) (6) (7) . With the use of the entrainment technique (10 -12) , we showed that a slow conduction zone with a conduction delay property in response to the increase in the pacing rate is present between the right ventricular outflow tract (RVOT) and the earliest ventricular activation site at the posteroapical left ventricular (LV) septum. In addition, we found that small doses of verapamil and lidocaine selectively suppress conduction through this slow conduction zone of ILVT (4, 5, 7) .
Recently, we reported that a discrete late diastolic potential (LDP) preceding the Purkinje potential (PP) was recorded in the middle to upper third LV septum during ILVT, and the entire slow conduction zone could be divided into two components by LDP: one in the distal part to the LDP recording site, showing a conduction delay property (the distal component), and the other in the proximal part to the LDP recording site, showing no conduction delay property (the proximal component) (7) . In the present study, we examined the responses of these two components to lidocaine (a sodium channel-blocking agent) and verapamil (a calcium channel-blocking agent) both during ventricular tachycardia (VT) and entrainment.
METHODS

Study patients.
Eight consecutive patients (6 men and 2 women, 16 to 44 years old) with recurrent, sustained VT and with no underlying heart disease were studied. The electrocardiogram (ECG) recorded during VT exhibited a right bundle branch block configuration and a superior or left axis in all patients. Intravenous verapamil (5 to 10 mg) was demonstrated to be effective in terminating VT in all patients. Electrophysiologic study. Written, informed consent was obtained from all patients before the study. All antiarrhythmic drugs were discontinued for Ͼ5 half-lives of each drug before the study. Using standard techniques, two or three 6F quadripolar electrode catheters (Josephson, Bard Electrophysiology, Billerica, Massachusetts) were placed at the right ventricular (RV) apex, RVOT and/or His bundle region and were used for recording bipolar electrograms and pacing. A 7F deflectable quadripolar electrode catheter with a 2-mm interelectrode interval (Radii-T, Cardiac Pathways, Sunnyvale, California) (n ϭ 8) or a 6F deflectable eight-pole electrode catheter with a 2.5-mm interelectrode interval (EPT-Dx-S, EP Technology, Sunnyvale, California) (n ϭ 4) was retrogradely inserted into the LV to perform endocardial mapping during VT to identify the earliest ventricular activation site and to record LDP by recording electrograms from the each electrode pair. All bipolar electrograms were filtered between a bandpass of 50 and 600 Hz and recorded simultaneously with three or six ECG leads (I, II, III, aVF, V 1 and V 5 ) with the use of a polygraph (Cardiolab system, Prucka Engineering, Houston, Texas). Ventricular pacing was performed at a stimulus strength of twice the diastolic threshold and with a pulse width of 2 ms, using a programmable stimulator (SEC-3102, Nihon Kohden, Tokyo, Japan). Entrainment from RVOT. Only the quadripolar catheter was used to record LDP in the entrainment study, because we could not stabilize the position of the eight-pole electrode catheter in the LV, and thus we could not record stable LDP during the entrainment study. We positioned the tip of the quadripolar catheter at the earliest LDP recording site and used this LDP in measuring local conduction times during entrainment as well as during VT. In all patients, entrainment of VT by pacing from the RVOT at a rate 5 to 10 beats/min faster than the induced VT rate was attempted while recording the LDP. When VT was still present after termination of the pacing, rapid pacing was again performed, with an increase in the pacing rate by 5 to 10 beats/min. This procedure was repeated until VT was interrupted or pacing reached the rate of 40 to 50 beats/min faster than the VT rate. In the last entrained beat, the intervals from the stimulus artifact to the electrogram at the RV apex (st-RVA) and from the stimulus artifact to the LDP (st-LDP), as well as that from the LDP to PP (LDP-PP), were measured at every pacing rate. Effects of lidocaine and verapamil during entrainment. During VT, lidocaine (1 mg/kg body weight over 1 min) was intravenously administered in six of eight patients, and the entrainment study was repeated. Approximately 15 min after the lidocaine study, when the VT rate and local conduction times returned to the control values, a small dose of verapamil (0.5 mg) was intravenously administered to all patients. When the VT rate was not decreased by about 20 beats/min, another dose of 0.5 mg (total dose 1.0 mg) was administered. The entrainment study was repeated in seven of eight patients. In the remaining one patient, verapamil (1.0 mg) resulted in VT termination, and the entrainment study was not performed. Throughout the study, we held the catheter carefully to avoid applying pressure at the tip of the catheter.
Before and after injection of each antiarrhythmic agent, the VT cycle length and the intervals from PP to the local ventricular potential (VP) (PP-VP), from VP to LDP (VP-LDP) and from LDP to PP (LDP-PP) were measured during VT. Measurements of st-LDP, st-RVA and LDP-PP during entrainment were repeated at every pacing rate after each antiarrhythmic agent. Data analysis. Continuous variables were expressed as the mean value Ϯ SD. Statistical analysis was done with repeated measures one-way analysis of variance, in which the F value was interpreted on the basis of Huyhn-Feld corrected p values. Subsequent multiple comparisons were performed by using a Bonferroni-type multiple comparison test for three or more variables. Correlations were tested by the Pearson correlation coefficient. For the analysis of the effect of verapamil on the relationship between LDP-PP and pacing rate, we performed a multiple regression analysis using a dummy variable to encode the treatment condition within each patient, as well as dummy variables to encode the eight different patients. A p value Ͻ0.05 was considered statistically significant.
RESULTS
Sustained VT with a mean cycle length of 342.8 Ϯ 49.3 ms (rate 178.3 Ϯ 26.1 beats/min) and with the same QRS morphology as that of spontaneous VT was repeatedly induced in all patients. Endocardial mapping during VT identified the earliest ventricular activation site at the posteroapical LV septum, with an activation time of Ϫ25.5 Ϯ 3.1 ms, relative to the onset of the QRS complex in all patients. The LDPs preceding PP were recorded serially from the upper third to the middle of the LV septum along the narrow longitudinal line in four patients in whom ventricular mapping with the eight-pole catheter was performed ( Fig. 1) . The LDP appeared earlier as the recording site became closer to the base of the LV. At the middle or lower third of the LV septum, the LDP appeared latest and was fused with PP. We used the earliest LDP in measuring the local conduction times. The LDP-PP, PP-VP and VP-LDP intervals at the earliest LDP recording site were 68.5 Ϯ 24. In one patient, verapamil induced a beat-to-beat variation in both the VT cycle length and LDP-PP and terminated VT, with local conduction block between the LDP and PP recording sites (Fig. 3) . Both PP-VP and VP-LDP were In all patients, entrainment phenomena, including constant fusion, except for the last entrained beat, and progressive fusion, were demonstrated by rapid pacing from the RVOT. A long conduction interval between the pacing site and the earliest ventricular activation site, indicating a slow conduction zone, was demonstrated during entrainment. We also performed VT entrainment while recording the earliest LDP and examined the effects of lidocaine and verapamil. The LDP was captured orthodromically during entrainment, whereas the ventricular potentials at the LDP recording site and RVA were captured antidromically. The st-LDP and LDP-PP, which were measured in the last entrained beat, were 319.1 Ϯ 34.8 ms and 81.9 Ϯ 34.8 ms, respectively, at the pacing cycle length of 320.7 Ϯ 49.6 ms. The st-RVA was 58.8 Ϯ 14.1 ms. It is noted that st-LDP was much longer than LDP-PP, and the percentages of st-LDP and LDP-PP to the interval from the stimulus artifact to PP, which was measured in the slowest pacing rate, were 80 Ϯ 5% and 20 Ϯ 5%, respectively (Table 1) . When the pacing rate was increased, LDP-PP was prolonged, whereas st-LDP and st-RVA remained unchanged in all patients. Figure 4 shows an example of the effects of lidocaine and verapamil on st-LDP, LDP-PP and st-RVA measured during entrainment. During the control study, st-LDP, LDP-PP and st-RVA were 370, 112 and 40 ms, respectively. After lidocaine administration, LDP was again captured orthodromically, and LDP-PP was prolonged to 168 ms, whereas st-LDP and st-RVA remained unchanged. After verapamil administration, LDP was captured orthodromically, and LDP-PP was further prolonged to 212 ms, whereas st-LDP and st-RVA remained unchanged. The effects of lidocaine (n ϭ 6) and verapamil (n ϭ 7) on local conduction times measured during entrainment are shown in Table 1 . In all patients, LDP-PP measured during entrainment was prolonged after lidocaine and was further prolonged after verapamil, although the pacing rate used for entrainment was lower, especially after verapamil, as compared with that during the control study. The st-LDP and st-RVA remained unchanged. The relationship between the LDP-PP interval and pacing rate was compared between the conditions during the control study and those after verapamil administration, by using multiple linear regression. The regression equation was expressed as follows: when LDP-PP was named "Y" and the pacing rate "X," Y ϭ Ϫ255.56 ϩ 44. Verapamil/Lidocaine for Verapamil-Sensitive Idiopathic VT Ϫ1); S 1 through S 7 are subject dummy variables; the number 12.91 in the term 12.91D is a intercept shift caused by verapamil; and Ϫ0.294 in the term Ϫ0.294X represents a verapamil-induced change in the slope in which p ϭ 0.0078. From these findings, the increase in LDP-PP in response to the increase in the pacing rate was augmented after verapamil administration.
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DISCUSSION
In this study, LDP preceding PP was recorded serially from the upper third to the middle of the LV septum along the narrow longitudinal line during VT. The earliest LDP was recorded at the base of the LV septum, whereas the latest LDP recorded at the middle or lower third of the LV septum was fused with PP. We measured the local conduction times with the use of the earliest LDP and found that the interval from the LDP to PP increased during entrainment in response to an increase in the pacing rate, whereas the st-LDP interval was constant. Thus, it is suggested that the earliest LDP reflects the excitation at the entrance of a "specific" component of slow conduction, and the following serially recorded LDPs might represent the serial excitations in this component.
Effects of lidocaine and verapamil on VT cycle length.
A small dose of verapamil and lidocaine selectively suppressed the conduction through the distal component, but neither of them affected the conduction in the proximal component, because LDP-PP was prolonged by the drugs, although PP-LDP was not. The increments in the VT cycle length after administering these drugs correlated with those in LDP-PP. Furthermore, in one patient, verapamil induced a beat-to-beat variation of the VT cycle length and LDP-PP interval and terminated VT, with local conduction block within the distal component. We held the catheter carefully throughout the study to avoid applying pressure at the tip of catheter, because pressure could cause the same phenomenon (7). Thus, verapamil and lidocaine slowed the VT rate by selectively suppressing the conduction through the distal component. Ventricular tachycardia entrainment and the effects of lidocaine and verapamil. To further elucidate this issue, we performed entrainment while recording LDP before and after lidocaine and verapamil administration. We found that verapamil selectively suppressed the conduction through the distal component, because LDP-PP, but not st-LDP, was prolonged after verapamil. The magnitude of the increase in LDP-PP with an increase in the pacing rate was augmented after verapamil. Thus, it is further confirmed that the target site of verapamil is confined to the distal component. This study also showed that lidocaine slightly but significantly suppressed the conduction through the distal component. The present dose of lidocaine is unlikely to affect conduction within the normal myocardium, unless the pacing rate is sufficiently high, but it might suppress conduction through the myocardial cells with partially depolarized membrane potential (13, 14) . These findings suggested that the main cellular mechanism of the conduction through the distal component is calcium channel-dependent and also involves depressed sodium channel-dependent tissue. In contrast, the conduction through the proximal component was affected by neither lidocaine nor verapamil, suggesting that the cellular mechanism of the proximal component is sodium channel-dependent (normal). The conduction time through the proximal component was relatively long and occupied 80 Ϯ 5% of the total conduction time from the stimulus artifact to PP during entrainment. Anatomically, it reflects conduction from the RVOT to the upper LV septum, and the distance was ϳ3 to 4 cm at most, if measured directly. In general, conduction velocity through tissue with normal sodium channel-dependent conduction is expected to be faster than that through tissue operated by the other cellular mechanism (13) . Thus, the conduction velocity in this proximal component is too slow to be explained by the conduction through the normal ventricular tissue with normal sodium channel-dependent conduction. It was reported that the conduction velocity of a fiber is reduced as the diameter is decreased and the length is increased (15) . Thus, we submit a hypothesis that the excitation in the proximal component is conducted along an anatomically isolated, long, thin pathway, such as the transverse LV false tendon. This structure, which extends from the posteroinferior LV to the LV septum, in many cases, was reported to be related to ILVT (16, 17) . Further studies are required to clarify this issue.
